Senior Manager, Immunoassay Development
Vaxcyte
Senior Manager, Immunoassay Development
Vaxcyte
Develops broad-spectrum vaccines for bacterial infections
Vaxcyte is seeking an accomplished Senior Manager, Immunoassay Developmentto join the CMC Immunoassay group. This role will provide scientific and strategic leadership for the development, qualification, characterization, governance, and lifecycle management of critical reagents and reference materials that support immunoassays across Vaxcyte's vaccine pipeline.
The Senior Manager will combine strong immunoassay technical experience with people leadership, operational discipline, resource planning, study prioritization, timeline management, data review, documentation oversight, and cross-functional coordination. This role will be accountable for ensuring that laboratory activities are planned, staffed, executed, documented, and delivered in alignment with CMC program needs.
Compared with the Staff Scientist role, this position has greater accountability for team management, daily lab execution, staff development, workload balancing, operational readiness, and delivery of assigned workstreams. The Senior Manager is expected to provide hands-on technical support when needed, but the primary accountability is leading people, managing laboratory execution, and ensuring reliable delivery.
Preferred Qualifications:
Equal Opportunity
We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.
Recruitment Fraud Notice
Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent Vaxcyte in recruitment activities. Vaxcyte has an established recruitment process for all positions prior to issuing an offer for employment and we will never extend unsolicited employment offers or ask candidates to provide financial or sensitive personal information as part of the application process. All legitimate communication from Vaxcyte will come from an official @vaxcyte.com email address. Qualified and interested candidates should apply to current openings at vaxcyte.com/careers.
Vaxcyte develops vaccines to prevent bacterial infections, focusing on broad-spectrum pneumococcal vaccines and other targets like Group A Strep, periodontitis, and Shigella. Its lead product, VAX-24, covers 24 Streptococcus pneumoniae strains and is produced using the XpressCF cell-free protein synthesis platform, which enables multi-strain conjugate vaccines. The company differentiates itself by combining cell-free manufacturing with broad strain coverage and has FDA Breakthrough Therapy designation for VAX-24, helping speed development. Its goal is to bring broadly protective bacterial vaccines to market, reduce serious infections worldwide, and expand its portfolio with products like VAX-31 and additional preclinical candidates.
Explore more opportunities at Vaxcyte